Results 131 to 140 of about 190,981 (166)

Modelling the metastatic immune microenvironment in triple-negative breast cancer. [PDF]

open access: yesBreast Cancer Res
de la Fuente LR   +8 more
europepmc   +1 more source

Cell Membrane‐Camouflaged Gold Nanoclusters/Nanoflowers for Synergistic Ferroptosis‐Like and Photothermal Therapy of Breast Cancer

open access: yesAggregate, Volume 7, Issue 3, March 2026.
Coated with cell membrane, CM‐NC@NF evades immune clearance, accumulates via EPR effect, and upon laser irradiation, generates ROS to induce ferroptosis‐like deth and photothermal therapy, enhancing cancer cell death. ABSTRACT Gold nanocluster (NC)‐induced ferroptosis has emerged as a promising method for malignant tumors. However, the immune clearance
Qixuan Wang   +8 more
wiley   +1 more source

Mannose‐Modified Cationic Liposome‐Based mRNA Therapeutics for Improved Triple‐Negative Breast Cancer Immunotherapy

open access: yesAdvanced NanoBiomed Research, Volume 6, Issue 3, March 2026.
Schematic illustration of mTEM8‐loaded cationic liposome (cLipo‐Man/mTEM8) therapeutics for improved triple‐negative breast cancer immunotherapy. Despite triple‐negative breast cancer (TNBC) is the most heterogeneous and aggressive subtype of breast cancer, immunotherapy is emerging as a promising therapy.
Kexin Deng   +10 more
wiley   +1 more source

LAP2α drives breast tumorigenesis by mitigating replication stress. [PDF]

open access: yesCell Death Dis
Ma Y   +10 more
europepmc   +1 more source

From Synthesis to Therapeutics: Bioactive‐Coated Zein Nanoparticles in Drug Delivery

open access: yesBiopolymers, Volume 117, Issue 2, March 2026.
ABSTRACT Polymeric zein nanoparticles (ZNP), derived from corn protein, are biodegradable drug carriers with high stability and low synthesis costs. Their amphiphilic nature allows efficient encapsulation of both hydrophilic and lipophilic drugs, making them promising for drug delivery.
Milena Ferreira de Lima   +8 more
wiley   +1 more source

Are There Socio‐Demographic Inequalities in the Utilisation of Tumour and ctDNA Somatic Mutation Testing in Solid Tumours? A Systematic Review

open access: yesCancer Medicine, Volume 15, Issue 3, March 2026.
This systematic review investigates whether inequalities exist in the utilisation of tumour and ctDNA somatic mutation testing in solid tumours. The review concludes that, across tumour types, testing modalities and socio‐demographic factors, inequalities exist and require further exploration.
Sarah Rae   +5 more
wiley   +1 more source

Male Breast Cancer: Growing Insights and Continuing Challenges

open access: yesCancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background Breast cancer (BC) in men accounts for less than 1% of all BC diagnoses worldwide. Despite its low incidence, the number of men being diagnosed is increasing. Historically perceived as a predominantly female disease, BC in men has received comparatively limited attention.
Sahar Iftikhar   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy